Dutch Medtech Startup Xeltis Secures €20.5 Million to Advance Vascular Implant Technology
Dutch‑US medtech startup Xeltis secured an additional €20.5 million, led by Horizon 3 Healthcare, to push forward its living‑tissue vascular implants, complete a pivotal US trial, and scale European commercialization and manufacturing.